BASSAM MALO
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- FENTON, MO
- NPI
- 1205148293
- Received
- $163,726 in 242 records, 2021 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 62 | $57,669 |
| 2024 | General payment | 65 | $55,103 |
| 2023 | General payment | 60 | $42,473 |
| 2022 | General payment | 26 | $7,920 |
| 2021 | General payment | 29 | $559 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| UCB, Inc. | 78 | $64,476 | 2023–2025 |
| GENZYME CORPORATION | 42 | $48,212 | 2022–2024 |
| Amgen Inc. | 18 | $21,096 | 2024–2025 |
| ARGENX US, INC. | 18 | $13,163 | 2022–2025 |
| Janssen Biotech, Inc. | 6 | $8,231 | 2024–2025 |
| Janssen Scientific Affairs, LLC | 5 | $3,175 | 2023–2024 |
| SANOFI-AVENTIS U.S. LLC | 1 | $2,165 | 2023 |
| ABBVIE INC. | 51 | $1,137 | 2021–2024 |
| MDD US Operations, LLC | 1 | $500 | 2023 |
| SK Life Science, Inc. | 4 | $361 | 2022–2024 |
| Alexion Pharmaceuticals, Inc. | 3 | $166 | 2023–2024 |
| Janssen Global Services, LLC | 1 | $142 | 2023 |
| Nevro Corp. | 1 | $138 | 2022 |
| Globus Medical, Inc. | 1 | $132 | 2025 |
| Biogen, Inc. | 1 | $117 | 2023 |
| Novo Nordisk Inc | 1 | $112 | 2024 |
| Lilly USA, LLC | 1 | $111 | 2025 |
| Amicus Therapeutics, Inc. | 3 | $101 | 2023–2025 |
| Janssen Pharmaceuticals, Inc | 1 | $89 | 2022 |
| PFIZER INC. | 4 | $65 | 2022–2025 |
| Tanabe Pharma America, Inc. | 1 | $28 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 52 | $117,617 |
| Consulting Fee | 15 | $24,819 |
| Travel and Lodging | 52 | $13,376 |
| Food and Beverage | 117 | $7,689 |
| Education | 6 | $224 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | OCTAGAM IMMUNE GLOBULIN (HUMAN) Drug, IMMUNOLOGY | 2025 | |
| 2025-12-18 | UCB, Inc. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-12-17 | Amgen Inc. | $2,062 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-12-17 | Amgen Inc. | $132 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-21 | Amgen Inc. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-21 | Amgen Inc. | $2,062 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-20 | UCB, Inc. | $1,680 | Consulting Fee | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-11-17 | Amgen Inc. | $3,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-14 | Amgen Inc. | $3,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-12 | Amgen Inc. | $125 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-06 | ARGENX US, INC. | $2,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-11-06 | ARGENX US, INC. | $90 | Travel and Lodging | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-10-16 | Amgen Inc. | $123 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-04 | Janssen Biotech, Inc. | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-03 | ARGENX US, INC. | $708 | Travel and Lodging | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-10-03 | ARGENX US, INC. | $383 | Travel and Lodging | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-10-03 | ARGENX US, INC. | $111 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-10-03 | ARGENX US, INC. | $55 | Travel and Lodging | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-09-30 | Janssen Biotech, Inc. | $1,123 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-09-30 | Janssen Biotech, Inc. | $124 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-18 | UCB, Inc. | $17 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-09-11 | UCB, Inc. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-09-11 | UCB, Inc. | $28 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-09-03 | UCB, Inc. | $630 | Consulting Fee | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-22 | UCB, Inc. | $160 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-21 | UCB, Inc. | $719 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-21 | Amgen Inc. | $687 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-08-21 | UCB, Inc. | $458 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-21 | UCB, Inc. | $297 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-21 | UCB, Inc. | $127 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-21 | UCB, Inc. | $55 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-21 | UCB, Inc. | $30 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-08-16 | Janssen Biotech, Inc. | $1,110 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-08-02 | Janssen Biotech, Inc. | $1,388 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-07-22 | Amgen Inc. | $117 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-07-21 | Amgen Inc. | $78 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-07-10 | ARGENX US, INC. | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-07-03 | UCB, Inc. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-06-12 | ARGENX US, INC. | $115 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-05-30 | ARGENX US, INC. | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-05-28 | ARGENX US, INC. | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-05-15 | UCB, Inc. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-05-01 | UCB, Inc. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-04-25 | ARGENX US, INC. | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-04-09 | Amgen Inc. | $141 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-08 | UCB, Inc. | $630 | Consulting Fee | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-04-08 | ARGENX US, INC. | $45 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-04-07 | ARGENX US, INC. | $125 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-04-07 | Amicus Therapeutics, Inc. | $29 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-06 | Amgen Inc. | $110 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-06 | UCB, Inc. | $64 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-06 | UCB, Inc. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-03-06 | UCB, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-03-06 | UCB, Inc. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2025-03-05 | Globus Medical, Inc. | $132 | Food and Beverage | Cash or cash equivalent | Senza Device, SPINAL CORD STIMULATOR | 2025 | |
| 2025-02-10 | UCB, Inc. | $1,795 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-02-10 | UCB, Inc. | $196 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-02-10 | UCB, Inc. | $120 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-01-30 | Lilly USA, LLC | $111 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-01-29 | UCB, Inc. | $159 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-01-24 | UCB, Inc. | $60 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-01-07 | UCB, Inc. | $945 | Consulting Fee | Cash or cash equivalent | Rystiggo Drug, Neurology | 2025 | |
| 2024-12-07 | GENZYME CORPORATION | $5,463 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LUMIZYME Biological, Genetic Disease | 2024 | |
| 2024-12-07 | GENZYME CORPORATION | $444 | Travel and Lodging | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2024 | |
| 2024-12-07 | GENZYME CORPORATION | $98 | Food and Beverage | In-kind items and services | LUMIZYME Biological, Genetic Disease | 2024 | |
| 2024-11-25 | Janssen Scientific Affairs, LLC | $1,050 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-14 | Janssen Scientific Affairs, LLC | $600 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-12 | UCB, Inc. | $1,680 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-10-28 | UCB, Inc. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Zilbrysq Drug, Neurology | 2024 | |
| 2024-10-18 | Alexion Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2024 | |
| 2024-10-17 | UCB, Inc. | $163 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-17 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-15 | Amgen Inc. | $4,125 | Consulting Fee | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-15 | Amgen Inc. | $1,650 | Consulting Fee | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-15 | GENZYME CORPORATION | $66 | Food and Beverage | In-kind items and services | FABRAZYME Biological, Genetic Disease | 2024 | |
| 2024-10-14 | UCB, Inc. | $338 | Travel and Lodging | In-kind items and services | Zilbrysq Drug, Neurology | 2024 | |
| 2024-10-14 | UCB, Inc. | $151 | Food and Beverage | In-kind items and services | Zilbrysq Drug, Neurology | 2024 | |
| 2024-10-09 | UCB, Inc. | $116 | Food and Beverage | In-kind items and services | Zilbrysq Drug, Neurology | 2024 | |
| 2024-10-05 | Amgen Inc. | $149 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-04 | Amgen Inc. | $150 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-09-26 | UCB, Inc. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-09-26 | UCB, Inc. | $99 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-09-18 | GENZYME CORPORATION | $1,530 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LUMIZYME Biological, Genetic Disease | 2024 | |
| 2024-09-17 | UCB, Inc. | $667 | Travel and Lodging | In-kind items and services | Zilbrysq Drug, Neurology | 2024 | |
| 2024-09-05 | ARGENX US, INC. | $109 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-04 | Novo Nordisk Inc | $112 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-27 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-08-22 | UCB, Inc. | $371 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-08-22 | UCB, Inc. | $273 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-08-22 | UCB, Inc. | $89 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-08-19 | Janssen Biotech, Inc. | $600 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-08-06 | UCB, Inc. | $60 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-07-26 | UCB, Inc. | $83 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-18 | UCB, Inc. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-07-18 | UCB, Inc. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Zilbrysq Drug, Neurology | 2024 | |
| 2024-07-08 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-07-05 | UCB, Inc. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-07-05 | UCB, Inc. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-07-05 | UCB, Inc. | $35 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-07-05 | UCB, Inc. | $35 | Travel and Lodging | Cash or cash equivalent | Zilbrysq Drug, Neurology | 2024 | |
| 2024-07-05 | UCB, Inc. | $35 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-07-05 | UCB, Inc. | $24 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-07-05 | UCB, Inc. | $24 | Travel and Lodging | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2024-07-05 | UCB, Inc. | $24 | Travel and Lodging | Cash or cash equivalent | Zilbrysq Drug, Neurology | 2024 | |
| 2024-06-12 | UCB, Inc. | $159 | Travel and Lodging | In-kind items and services | Zilbrysq Drug, Neurology | 2024 | |
| 2024-06-12 | UCB, Inc. | $125 | Food and Beverage | In-kind items and services | Zilbrysq Drug, Neurology | 2024 | |
| 2024-06-12 | UCB, Inc. | $25 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-06-11 | UCB, Inc. | $389 | Travel and Lodging | In-kind items and services | Zilbrysq Drug, Neurology | 2024 | |
| 2024-06-11 | UCB, Inc. | $389 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-06-11 | UCB, Inc. | $389 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-06-11 | UCB, Inc. | $101 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-06-11 | UCB, Inc. | $87 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-06-11 | UCB, Inc. | $87 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-06-05 | UCB, Inc. | $20 | Travel and Lodging | In-kind items and services | Zilbrysq Drug, Neurology | 2024 | |
| 2024-06-05 | UCB, Inc. | $20 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-06-05 | UCB, Inc. | $20 | Travel and Lodging | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-06-01 | GENZYME CORPORATION | $2,622 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-05-29 | UCB, Inc. | $122 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2024 | |
| 2024-05-28 | GENZYME CORPORATION | $87 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-30 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | OCTAGAM IMMUNE GLOBULIN (HUMAN) Drug, IMMUNOLOGY | 2024 | |
| 2024-03-29 | GENZYME CORPORATION | $1,419 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-03-21 | UCB, Inc. | $840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Zilbrysq Drug, Neurology | 2024 | |
| 2024-03-20 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-03-13 | SK Life Science, Inc. | $124 | Food and Beverage | In-kind items and services | XCOPRI Drug, Neurology | 2024 | |
| 2024-02-06 | GENZYME CORPORATION | $1,530 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LUMIZYME Biological, Genetic Disease | 2024 | |
| 2024-01-31 | Tanabe Pharma America, Inc. | $28 | Education | In-kind items and services | RADICAVA Drug, AMYOTROPHIC LATERAL SCLEROSIS | 2024 | |
| 2024-01-11 | UCB, Inc. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Rystiggo Drug, Neurology | 2024 | |
| 2023-12-07 | UCB, Inc. | $1,050 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-11-29 | UCB, Inc. | $3,360 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Zilbrysq Drug, Neurology | 2023 | |
| 2023-11-15 | Janssen Scientific Affairs, LLC | $1,350 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-11-05 | UCB, Inc. | $188 | Travel and Lodging | In-kind items and services | Zilbrysq Drug, Neurology | 2023 | |
| 2023-11-05 | UCB, Inc. | $8 | Food and Beverage | In-kind items and services | Zilbrysq Drug, Neurology | 2023 | |
| 2023-11-04 | UCB, Inc. | $293 | Food and Beverage | In-kind items and services | Zilbrysq Drug, Neurology | 2023 | |
| 2023-11-04 | UCB, Inc. | $283 | Travel and Lodging | In-kind items and services | Zilbrysq Drug, Neurology | 2023 | |
| 2023-11-04 | UCB, Inc. | $212 | Travel and Lodging | In-kind items and services | Zilbrysq Drug, Neurology | 2023 | |
| 2023-11-03 | UCB, Inc. | $147 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-02 | UCB, Inc. | $150 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-02 | Janssen Global Services, LLC | $142 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-01 | GENZYME CORPORATION | $4,180 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LUMIZYME Biological, Genetic Disease | 2023 | |
| 2023-11-01 | GENZYME CORPORATION | $432 | Travel and Lodging | In-kind items and services | LUMIZYME Biological, Genetic Disease | 2023 | |
| 2023-11-01 | GENZYME CORPORATION | $353 | Travel and Lodging | Cash or cash equivalent | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-11-01 | Janssen Scientific Affairs, LLC | $144 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-01 | Janssen Scientific Affairs, LLC | $31 | Travel and Lodging | In-kind items and services | 2023 | ||
| 2023-10-31 | GENZYME CORPORATION | $380 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LUMIZYME Biological, Genetic Disease | 2023 | |
| 2023-10-31 | GENZYME CORPORATION | $96 | Food and Beverage | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-10-17 | MDD US Operations, LLC | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | APOKYN Drug, NEUROLOGY | 2023 | |
| 2023-09-26 | UCB, Inc. | $106 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-09-25 | ARGENX US, INC. | $25 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2023 | |
| 2023-08-29 | GENZYME CORPORATION | $1,330 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-08-23 | Alexion Pharmaceuticals, Inc. | $108 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2023 | |
| 2023-07-31 | GENZYME CORPORATION | $4,180 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-07-31 | GENZYME CORPORATION | $1,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-07-31 | GENZYME CORPORATION | $1,330 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2023 | ||
| 2023-07-31 | GENZYME CORPORATION | $223 | Travel and Lodging | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-07-31 | GENZYME CORPORATION | $219 | Travel and Lodging | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-07-31 | GENZYME CORPORATION | $218 | Travel and Lodging | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-07-31 | GENZYME CORPORATION | $171 | Travel and Lodging | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-07-31 | GENZYME CORPORATION | $111 | Food and Beverage | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-07-19 | Alexion Pharmaceuticals, Inc. | $34 | Education | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2023 | |
| 2023-07-11 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-06-29 | UCB, Inc. | $143 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-06-16 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-06-14 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-06-01 | SANOFI-AVENTIS U.S. LLC | $2,165 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-05-23 | UCB, Inc. | $4 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-09 | GENZYME CORPORATION | $3,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-05-09 | GENZYME CORPORATION | $312 | Travel and Lodging | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-05-09 | GENZYME CORPORATION | $219 | Travel and Lodging | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-05-09 | GENZYME CORPORATION | $99 | Food and Beverage | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-04-18 | ARGENX US, INC. | $28 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2023 | |
| 2023-04-14 | Amicus Therapeutics, Inc. | $35 | Education | In-kind items and services | POMBILITI Drug, POMPE DISEASE | 2023 | |
| 2023-04-14 | Amicus Therapeutics, Inc. | $35 | Education | In-kind items and services | POMBILITI Drug, POMPE DISEASE | 2023 | |
| 2023-03-21 | Biogen, Inc. | $117 | Food and Beverage | In-kind items and services | SPINRAZA Biological, Neurology | 2023 | |
| 2023-03-21 | GENZYME CORPORATION | $45 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-03-20 | GENZYME CORPORATION | $93 | Food and Beverage | In-kind items and services | NEXVIAZYME Biological, Genetic Disease | 2023 | |
| 2023-03-14 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-03-08 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-03-07 | GENZYME CORPORATION | $1,995 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2023 | ||
| 2023-03-07 | GENZYME CORPORATION | $86 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-03-02 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-02-14 | ARGENX US, INC. | $3,750 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-02-07 | GENZYME CORPORATION | $570 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LUMIZYME Biological, Genetic Disease | 2023 | |
| 2023-01-16 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-01-01 | GENZYME CORPORATION | $4,940 | Consulting Fee | Cash or cash equivalent | LUMIZYME Biological, Genetic Disease | 2023 | |
| 2023-01-01 | GENZYME CORPORATION | $400 | Consulting Fee | In-kind items and services | LUMIZYME Biological, Genetic Disease | 2023 | |
| 2023-01-01 | GENZYME CORPORATION | $260 | Travel and Lodging | Cash or cash equivalent | LUMIZYME Biological, Genetic Disease | 2023 | |
| 2023-01-01 | GENZYME CORPORATION | $71 | Travel and Lodging | Cash or cash equivalent | LUMIZYME Biological, Genetic Disease | 2023 | |
| 2022-11-11 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-10-18 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-09-22 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-09-22 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2022 | |
| 2022-08-30 | ARGENX US, INC. | $15 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2022 | |
| 2022-06-29 | SK Life Science, Inc. | $120 | Food and Beverage | In-kind items and services | XCOPRI Drug, Neurology | 2022 | |
| 2022-06-21 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-06-16 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-06-16 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-06-13 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-05-25 | GENZYME CORPORATION | $1,274 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NEXVIAZYME Biological, Genetic Disease | 2022 | |
| 2022-05-25 | GENZYME CORPORATION | $1,274 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NEXVIAZYME Biological, Genetic Disease | 2022 | |
| 2022-05-19 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 |
The latest 200 records of 242.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Fenton, MO, county St. Louis County, MO, state Missouri; placed by its city name.
| Measure | Place (city or town) Fenton, MO | County St. Louis County, MO | State Missouri |
|---|---|---|---|
| Population B01003 | 4,088 | 995,569 | 6,191,814 |
| Population, 2020 census P1 | 3,989 | 1,004,125 | 6,154,913 |
| Median age B01002 | 48.0 | 40.3 | 39.0 |
| Under 18 B01001 | 18.8% | 22.0% | 22.3% |
| 65 and over B01001 | 23.2% | 19.1% | 17.9% |
| Households B11001 | 1,612 | 413,849 | 2,508,227 |
| Foreign born B05002 | 3.5% | 8.4% | 4.5% |
| Median household income B19013 | $101,000 | $82,936 | $70,702 |
| Median family income B19113 | $117,120 | $110,950 | $91,360 |
| Per capita income B19301 | $50,479 | $51,977 | $39,695 |
| Poverty rate B17001 | 3.5% | 9.8% | 12.6% |
| Unemployment rate B23025 | 8.1% | 4.3% | 4.0% |
| Civilian labor force B23025 | 2,196 | 521,387 | 3,120,639 |
| Mean commute (minutes) B08013 | 25.0 | 23.1 | 23.5 |
| Bachelor's degree or higher B15003 | 49.3% | 47.4% | 32.4% |
| Housing units B25001 | 1,655 | 446,192 | 2,825,287 |
| Owner-occupied B25003 | 82.6% | 69.2% | 68.1% |
| Renters B25003 | 17.4% | 30.8% | 31.9% |
| Median home value B25077 | $374,500 | $276,800 | $230,300 |
| Median gross rent B25064 | $1,622 | $1,209 | $1,033 |
| White, not Hispanic B03002 | 86.1% | 61.4% | 76.3% |
| Black B03002 | 0.2% | 24.0% | 10.9% |
| Hispanic or Latino B03002 | 2.4% | 3.9% | 5.2% |
| Asian B03002 | 2.0% | 4.9% | 2.1% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Fenton, MO.
Comments